Treatment of insulin-resistant mice with the oral antidiabetic agent pioglitazone: evaluation of liver GLUT2 and phosphoenolpyruvate carboxykinase expression. [electronic resource]
Producer: 19920303Description: 735-40 p. digitalISSN:- 0013-7227
- Animals
- Crosses, Genetic
- Diabetes Mellitus -- genetics
- Diabetes Mellitus, Experimental -- genetics
- Female
- Hypoglycemic Agents -- pharmacology
- Insulin -- blood
- Insulin Resistance
- Kinetics
- Liver -- drug effects
- Male
- Mice
- Mice, Inbred C57BL
- Mice, Obese
- Monosaccharide Transport Proteins -- genetics
- Obesity
- Phosphoenolpyruvate Carboxykinase (GTP) -- genetics
- Pioglitazone
- RNA, Messenger -- genetics
- Thiazoles -- pharmacology
- Thiazolidinediones
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.